Index Entries - Covid Index

1616 Results

Title	IS Publication Date
SARS-CoV-2 antibodies persist up to 12 months after natural infection in healthy employees working in non-medical contact-intensive professions	November 24, 2022
SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy	April 27, 2021
SARS-CoV-2 B.1.1.529 (Omicron) Variant — United States, December 1–8, 2021	December 17, 2021
SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19	September 8, 2020
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor	March 5, 2020
SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity	June 4, 2021
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans	May 24, 2021
SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19	March 22, 2021
SARS-CoV-2 Is an Unrestricted Bioweapon: A Truth Revealed through Uncovering a Large-Scale, Organized Scientific Fraud	October 8, 2020
SARS-CoV-2 mRNA Vaccination-Associated Myocarditis in Children Ages 12-17: A Stratified National Database Analysis	August 30, 2021
SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels	September 17, 2020
SARS-CoV-2 Proteins Interact with Alpha Synuclein and Induce Lewy Body-like Pathology In Vitro	March 21, 2022
SARS-CoV-2 re-infection risk in Austria	February 13, 2021
SARS-CoV-2 S1 Protein Persistence in SARS-CoV-2 Negative Post-Vaccination Individuals with Long COVID/ PASC-Like Symptoms	July 12, 2022
SARS-CoV-2 Spike Glycoprotein S1 Induces Neuroinflammation in BV-2 Microglia	October 28, 2021
SARS-CoV-2 spike mRNA vaccine sequences circulate in blood up to 28 days after COVID-19 vaccination	January 17, 2023
SARS-CoV-2 Spike Protein Accumulation in the Skull-Meninges-Brain Axis: Potential Implications for Long-Term Neurological Complications in post-COVID-19	April 5, 2023
SARS-CoV-2 spike protein alone may cause lung damage	April 27, 2021
SARS-CoV-2 Spike Protein and Its Receptor Binding Domain Promote a Proinflammatory Activation Profile on Human Dendritic Cells	November 23, 2021
SARS-CoV-2 Spike Protein and Lung Vascular Cells	December 30, 2020
SARS-CoV-2 Spike Protein Disrupts Blood–Brain Barrier Integrity via RhoA Activation	October 23, 2021
SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Host Cells: Implications for Possible Consequences of COVID-19 Vaccines	January 11, 2021
SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2	March 31, 2021
SARS-CoV-2 spike protein induces cognitive deficit and anxiety-like behavior in mouse via non-cell autonomous hippocampal neuronal death	March 31, 2022
SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity	June 11, 2021
SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects
SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration	March 24, 2021
SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19	August 20, 2021
SARS-CoV-2 Spike protein S2 subunit modulates γ-secretase and enhances amyloid-β production in COVID-19 neuropathy	September 30, 2022
SARS-CoV-2 Spike protein suppresses CTL-mediated killing by inhibiting immune synapse assembly	November 15, 2022
SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies	August 2, 2021
SARS-CoV-2 spike S2 subunit inhibits p53 activation of p21(WAF1), TRAIL Death Receptor DR5 and MDM2 proteins in cancer cells	April 15, 2024
SARS-CoV-2 Spike Targets USP33-IRF9 Axis via Exosomal miR-148a to Activate Human Microglia	April 14, 2021
SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signaling	December 9, 2022
SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents	April 20, 2022
SARS-CoV-2 Vaccination and the Multi-Hit Hypothesis of Oncogenesis	December 17, 2023
SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis	April 21, 2022
SARS-CoV-2 Vaccination-Induced Thrombotic Thrombocytopenia: A Rare but Serious Immunologic Complication	July 18, 2022
SARS-CoV-2 vaccine and increased myocarditis mortality risk: A population based comparative study in Japan	December 22, 2022
SARS-CoV-2 Vaccine Breakthrough Surveillance and Case Information Resource	October 27, 2021
SARS-CoV-2 vaccine protection and deaths among US veterans during 2021	November 4, 2021
SARS-CoV-2 variants of concern and variants under investigation in England - Technical briefing 20	August 6, 2021
SARS-CoV-2 variants of concern and variants under investigation in England – Technical briefing 23	September 17, 2021
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls	July 15, 2020
SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells	June 30, 2021
SARS-CoV2 spike protein pathogenicity research collection	December 3, 2024
SARS-CoV2 vaccine and viral variant research library	January 3, 2025
SARS-like WIV1-CoV poised for human emergence	March 14, 2016
School children’s mental health during the COVID-19 pandemic	January 4, 2024
Science Committee hearing: Testimony of Dr. Peter Hotez	March 5, 2020

Page 25 of 33